Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Journal Belge De Radiologie
|
February 28, 1998
Epidermoid cyst
M Roosendaal, R Ceulemans
Journal Belge De Radiologie
|
January 1, 1982
[Pneumatocele and pulmonary hematoma following chest injury]
M Roosendaal, R Colebunders, L Mortelmans
European Journal of Neurology
|
October 30, 2009
The paradox of intracranial hypotension responding well to CSF drainage
C M Roosendaal, M H Coppes, P C A J Vroomen
The Veterinary Quarterly
|
October 1, 1989
Intravenous catheterisation of conventional pigs without application of antimicrobial agents
A Pijpers, E N Noordhuizen-Stassen, S A Goedegebuure, et al.
Neurology
|
January 21, 2018
Electrophysiologic testing aids diagnosis and subtyping of myoclonus
Rodi Zutt, Jan W Elting, Jonathan C van Zijl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Alyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Alyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
Liza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Journal of the Neurological Sciences
|
June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
A A Toorop, M H J Wessels, L M Y Gelissen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Journal Belge De Radiologie
|
February 28, 1998
Epidermoid cyst
M Roosendaal, R Ceulemans
Journal Belge De Radiologie
|
January 1, 1982
[Pneumatocele and pulmonary hematoma following chest injury]
M Roosendaal, R Colebunders, L Mortelmans
European Journal of Neurology
|
October 30, 2009
The paradox of intracranial hypotension responding well to CSF drainage
C M Roosendaal, M H Coppes, P C A J Vroomen
The Veterinary Quarterly
|
October 1, 1989
Intravenous catheterisation of conventional pigs without application of antimicrobial agents
A Pijpers, E N Noordhuizen-Stassen, S A Goedegebuure, et al.
Neurology
|
January 21, 2018
Electrophysiologic testing aids diagnosis and subtyping of myoclonus
Rodi Zutt, Jan W Elting, Jonathan C van Zijl, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
January 13, 2023
Decrease of natalizumab drug levels after switching from intravenous to subcutaneous administration in patients with multiple sclerosis
Alyssa A Toorop, Zoé L E van Kempen, Maurice Steenhuis, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
November 4, 2024
Serum neurofilament light and glial fibrillary acidic protein levels are not associated with wearing-off symptoms in natalizumab-treated multiple sclerosis patients
Alyssa A Toorop, Mark Hj Wessels, Lynn Boonkamp, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 25, 2025
Low natalizumab trough concentrations are associated with reduced seroconversion of the John Cunningham virus in natalizumab-treated patients with multiple sclerosis
Liza M Y Gelissen, Alyssa A Toorop, Pien M Schipper, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 14, 2023
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS)
Alyssa A Toorop, Zoë Ygj van Lierop, Liza My Gelissen, et al.
Journal of the Neurological Sciences
|
June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial
A A Toorop, M H J Wessels, L M Y Gelissen, et al.
Page
of 1